Showing 1 - 7 results of 7 for search 'Breelyn A. Wilky', query time: 0.04s Refine Results
  1. 1
    High grade sarcoma presenting as multifocal recurrent seromas after inguinal hernia repair: A case report

    High grade sarcoma presenting as multifocal recurrent seromas after inguinal hernia repair: A case report by Lorne D Muir, Joshua D Woelfle, Jeffrey Schowinsky, Breelyn A Wilky

    Published 2020-11-01
    Get full text
    Article
  2. 2
    Treatment with a Small Molecule Mutant IDH1 Inhibitor Suppresses Tumorigenic Activity and Decreases Production of the Oncometabolite 2-Hydroxyglutarate in Human Chondrosarcoma Cells.

    Treatment with a Small Molecule Mutant IDH1 Inhibitor Suppresses Tumorigenic Activity and Decreases Production of the Oncometabolite 2-Hydroxyglutarate in Human Chondrosarcoma Cell... by Luyuan Li, Ana C Paz, Breelyn A Wilky, Britt Johnson, Karina Galoian, Andrew Rosenberg, Guozhi Hu, Gabriel Tinoco, Olaf Bodamer, Jonathan C Trent

    Published 2015-01-01
    Get full text
    Article
  3. 3
    Angiosarcoma patients treated with immune checkpoint inhibitors: a case series of seven patients from a single institution

    Angiosarcoma patients treated with immune checkpoint inhibitors: a case series of seven patients from a single institution by Vaia Florou, Andrew E. Rosenberg, Eric Wieder, Krishna V. Komanduri, Despina Kolonias, Mohamed Uduman, John C. Castle, Jennifer S. Buell, Jonathan C. Trent, Breelyn A. Wilky

    Published 2019-08-01
    Get full text
    Article
  4. 4
    Correction to: Angiosarcoma patients treated with immune checkpoint inhibitors: a case series of seven patients from a single institution

    Correction to: Angiosarcoma patients treated with immune checkpoint inhibitors: a case series of seven patients from a single institution by Vaia Florou, Andrew E. Rosenberg, Eric Wieder, Krishna V. Komanduri, Despina Kolonias, Mohamed Uduman, John C. Castle, Jennifer S. Buell, Jonathan C. Trent, Breelyn A. Wilky

    Published 2019-11-01
    Get full text
    Article
  5. 5
    Cell-cycle dependent expression of a translocation-mediated fusion oncogene mediates checkpoint adaptation in rhabdomyosarcoma.

    Cell-cycle dependent expression of a translocation-mediated fusion oncogene mediates checkpoint adaptation in rhabdomyosarcoma. by Ken Kikuchi, Simone Hettmer, M Imran Aslam, Joel E Michalek, Wolfram Laub, Breelyn A Wilky, David M Loeb, Brian P Rubin, Amy J Wagers, Charles Keller

    Published 2014-01-01
    Get full text
    Article
  6. 6
    LGR5 is expressed by Ewing sarcoma and potentiates Wnt/β-catenin signaling

    LGR5 is expressed by Ewing sarcoma and potentiates Wnt/β-catenin signaling by Christopher A Scannell, Christopher A Scannell, Elisabeth A Pedersen, Jack T Mosher, Melanie Anne Krook, Lauren A Nicholls, Breelyn A Wilky, David M. Loeb, Elizabeth R Lawlor, Elizabeth R Lawlor

    Published 2013-04-01
    Get full text
    Article
  7. 7
    RNA helicase DDX3 regulates RAD51 localization and DNA damage repair in Ewing sarcoma

    RNA helicase DDX3 regulates RAD51 localization and DNA damage repair in Ewing sarcoma by Matthew E. Randolph, Marwa Afifi, Aparna Gorthi, Rachel Weil, Breelyn A. Wilky, Joshua Weinreb, Paul Ciero, Natalie ter Hoeve, Paul J. van Diest, Venu Raman, Alexander J.R. Bishop, David M. Loeb

    Published 2024-02-01
    Get full text
    Article

Search Tools: